Lupus Erythematosus Tumidus Clinical Characteristics and Treatment: A Retrospective Review of 25 Patients.
Pona A, Cardenas-de la Garza JA, Broderick A, Sangueza OP, Niehaus AG, Bowers N, Pichardo RO.
Cutis. 2022 Jun;109(6):330-332. doi: 10.12788/cutis.0544.
Lupus erythematosus tumidus: clinical perspectives.
Patsinakidis N, Kautz O, Gibbs BF, Raap U.
Clin Cosmet Investig Dermatol. 2019 Oct 1;12:707-719. doi: 10.2147/CCID.S166723. eCollection 2019.
Refractory lupus erythematosus tumidus responsive to tildrakizumab.
Ismail FF, Sinclair RD, Pinczewski J.
Dermatol Ther. 2019 Sep;32(5):e13070. doi: 10.1111/dth.13070. Epub 2019 Sep 3.
Atorvastatin-induced Lupus Erythematosus Tumidus: A Case Report and Literature Review.
Trčko K, Lukinovič N, Luzar B.
Acta Dermatovenerol Croat. 2023 Dec;31(3):125-132.
Lupus Erythematosus Tumidus Associated With Hemophagocytosis.
Georgiadou N, Singh S, Singh M.
Am J Dermatopathol. 2022 Jul 1;44(7):519-522. doi: 10.1097/DAD.0000000000002188. Epub 2022 Apr 6.
Lupus erythematosus tumidus.
Choonhakarn C, Poonsriaram A, Chaivoramukul J.
Int J Dermatol. 2004 Nov;43(11):815-8. doi: 10.1111/j.1365-4632.2004.02073.x.
Lupus erythematosus tumidus.
Pakran J, George M, Rajan U, Lekha T, Muhammed K.
Indian J Dermatol Venereol Leprol. 2011 Mar-Apr;77(2):253. doi: 10.4103/0378-6323.77492.
Clinical, Histopathological, and Therapeutic Features in Lupus Erythematosus Tumidus: A Retrospective Study.
La Rotta-Higuera E, Morgado-Carrasco D, Mansilla-Polo M, Giavedoni P, García-Herrera A, Mascaró JM Jr.
Actas Dermosifiliogr. 2025 Jun;116(6):628-632. doi: 10.1016/j.ad.2024.02.038. Epub 2025 Feb 11.
Unilateral periorbital lupus erythematosus tumidus mimicking heliotrope rash.
Yamamoto M, Saito M, Yamamoto T.
J Dermatol. 2023 Mar;50(3):e100-e101. doi: 10.1111/1346-8138.16629. Epub 2022 Nov 1.
Lupus tumidus.
Dekle CL, Mannes KD, Davis LS, Sangueza OP.
J Am Acad Dermatol. 1999 Aug;41(2 Pt 1):250-3. doi: 10.1016/s0190-9622(99)70056-3.
